Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,821 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06076226Recruiting
Donor telomere length and leukemia transplant outcomes
This trial looks at whether the length of telomeres (the protective caps at the ends of chromosomes) in donor blood cells affects recovery for people with acute leukemia who receive a stem cell transplant. It aims to see if a simple donor blood test can predict how well the transplant works.
Hangzhou, ZhejiangAges 5–90 - NCT06128980RecruitingPhase 2/Phase 3
Stopping heart meds after recovery from fast heartbeat damage
This trial tests if patients whose heart function returned to normal after treating a fast heartbeat can safely stop their heart failure medications. It aims to see if treatment can be withdrawn without the heart problems coming back.
CopenhagenAges 18 years+ - NCT06026657RecruitingPhase 1/Phase 2
NK cells with or without naxitamab for GD2-positive breast cancer
This trial tests a new treatment using immune cells called NK cells combined with chemotherapy (gemcitabine) and possibly naxitamab for people with a certain type of advanced breast cancer that has spread. It aims to see if this approach can help when standard treatments have stopped working.
Columbus, OhioAges 18 years+ - NCT05947825Enrolling by invitationPhase 2
Sitagliptin plus chemo for advanced pancreatic cancer
This trial tests adding sitagliptin (a diabetes drug) to standard chemotherapy (gemcitabine and nab-paclitaxel) for people with pancreatic cancer that has spread or cannot be removed by surgery. The goal is to see if the combination works better than chemo alone.
TianjingAges 18 years+ - NCT06051214Recruiting
Predicting blood clots in cancer patients at risk
This trial studies how your blood's ability to clot changes over time in people with certain cancers who have not yet started treatment. The goal is to better predict who might develop a dangerous blood clot, so that preventative steps can be taken.
Saint-HerblainAges 18 years+ - NCT06058572RecruitingPhase 2
Rifaximin for gut bacteria after stem cell transplant in leukemia
This trial tests whether the antibiotic rifaximin can help protect the healthy bacteria in your gut after a stem cell transplant for acute leukemia. It may reduce infections and other complications during your recovery.
Navi Mumbai, MaharashtraAges 18–70 - NCT06085625RecruitingPhase 2
Outpatient vs. Overnight Stay After Thyroid Lobectomy
This study compares patient-reported outcomes and safety for patients who have thyroid lobectomy as an outpatient (go home the same day) versus an overnight stay in the hospital. It may be a good fit if you live within 50 miles of the hospital, have someone to help you at home for a few days, and are not at high risk for bleeding complications.
Houston, TexasAges 18 years+ - NCT06033300Recruiting
Blood cell clumps in heparin-induced low platelets
This study looks at how blood cells clump together in patients who may have heparin-induced thrombocytopenia (HIT), a condition where heparin causes a drop in platelets. It aims to better understand the disease and improve diagnosis.
AmiensAges 18 years+ - NCT06019637Recruiting
Long-term safety study of Zolgensma for spinal muscular atrophy
This study follows the long-term safety of Zolgensma gene therapy in Brazilian children with spinal muscular atrophy (SMA). It helps doctors understand how safe the treatment is over time.
Curitiba, ParanáAges birth–100 years - NCT06026436Recruiting
Predicting clot and bleeding risk in kidney disease patients after a heart attack
This trial tests whether a blood test looking at platelets and tiny cell particles can help predict future blood clots or bleeding in people who have both chronic kidney disease and a recent heart attack. The goal is to improve treatment safety.
MarseilleAges 18–90 - NCT05933174Recruiting
Switching away from sulfonylureas in type 2 diabetes safety care
This trial helps patients and their primary care team consider safer alternatives to sulfonylurea pills for type 2 diabetes. It may help reduce risks from sulfonylureas by improving how treatment changes are discussed and supported in routine care.
Cleveland, OhioAges 45 years+ - NCT06085937RecruitingPhase 1
Ketamine for suicidal patients in the ER
This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.
Kansas City, KansasAges 18–65 - NCT06031571Recruiting
Cupping vs myofascial release for neck pain
This trial compares two hands-on treatments for long-term neck pain that isn't caused by injury or serious spine problems. It aims to see if dynamic cupping or myofascial release works better to relieve pain.
Qina, Qena GovernorateAges 18–40 - NCT05975697Recruiting
Electrical stimulation after thrombectomy for arm paralysis
This study tests whether a special electrical stimulation therapy can improve arm movement, physical activity, and quality of life after a thrombectomy. You may be considered if you are an adult with arm paralysis and can communicate after your procedure.
Adana, YüreğirAges 18 years+ - NCT06117540RecruitingPhase 2
WX390 for advanced solid tumors after standard treatment
This trial tests a new drug called WX390 for people whose advanced solid tumors have not responded to standard treatments. The study aims to see if WX390 can help shrink or slow the growth of these tumors.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT05934682Recruiting
Study of surgery outcomes in children
This study looks at how pediatric patients do after different types of planned and unplanned surgeries at participating hospitals. It may help doctors improve care and safety for children undergoing surgery.
São Paulo, São PauloAges 1 day–18 years - NCT05693506Recruiting
Remote cooking workshops for adults with obesity
This study tests whether online cooking classes can help adults with obesity improve healthy eating habits. You would attend workshops from home by video and answer questionnaires during the study.
Briis-sous-ForgesAges 18–75 - NCT05825014Recruiting
Using computer prediction to reduce COPD complications
This study uses information from past hospital discharge records and breathing test results to predict who with COPD may have worse health outcomes later. It may help future COPD care by identifying higher-risk patients earlier.
Hong Kong, New TerritoriesAges 40 years+ - NCT05897125Enrolling by invitation
Telehealth education to help people with COPD after a hospital stay
This study tests whether a telehealth (video/phone) education program can help people with COPD better manage their health after a hospital flare-up. It may reduce the chance of needing to return to the hospital soon after discharge.
Chicago, IllinoisAges 18 years+ - NCT05845801Recruiting
Study registry for young adults with pancreatic cancer
This study is a registry, meaning it collects information about young adults diagnosed with pancreatic cancer. It may help researchers better understand this cancer in younger people and improve future care.
VeronaAges 18–55 - NCT05683717RecruitingPhase 1
First-dose test of TT-01488 for B-cell cancers
This Phase 1 study tests whether TT-01488 is safe and tolerable in people with B-cell malignancies (blood cancers). It’s meant for patients whose disease has come back or did not respond after standard treatments.
Nanjing, JiangsuAges 18 years+ - NCT05676827Enrolling by invitation
Study pain and stress in people with long-term jaw muscle pain
This trial looks at how long-lasting jaw (masticatory) muscle pain relates to the nervous system and emotional stress. It may help researchers understand why symptoms persist and guide future treatments.
WroclawAges 18–80 - NCT05756322RecruitingPhase 1/Phase 2
Study medicine LBS-007 for relapsed leukemia patients
This trial tests how safe and tolerable LBS-007 is for adults with AML or ALL that has come back or is resistant to treatment. It may help people who can’t use standard therapies or have no proven treatment options.
Tampa, FloridaAges 18–120 - NCT05754853RecruitingPhase 3
MRG002 antibody compared with standard chemo for HER2 bladder cancer
This trial studies whether MRG002, a targeted antibody treatment, works better than the patient’s chosen standard chemotherapy. It is for people with HER2-positive advanced or metastatic urothelial (bladder/urinary tract) cancer whose disease has progressed after prior platinum chemotherapy and immunotherapy.
Beijing, Beijing MunicipalityAges 18–75
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,821 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.